183 related articles for article (PubMed ID: 37426645)
21. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death.
Lange PT; Damania B
mBio; 2023 Apr; 14(2):e0345922. PubMed ID: 36786572
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells.
Kanavaros P; Briere J; Lescs MC; Gaulard P
J Pathol; 1996 Mar; 178(3):297-302. PubMed ID: 8778335
[TBL] [Abstract][Full Text] [Related]
24. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas.
Kim SJ; Hyeon J; Cho I; Ko YH; Kim WS
Cancer Res Treat; 2019 Apr; 51(2):611-622. PubMed ID: 30025443
[TBL] [Abstract][Full Text] [Related]
27. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.
Hagberg N; Theorell J; Hjorton K; Spee P; Eloranta ML; Bryceson YT; Rönnblom L
Arthritis Rheumatol; 2015 Apr; 67(4):1000-11. PubMed ID: 25510434
[TBL] [Abstract][Full Text] [Related]
28. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
[TBL] [Abstract][Full Text] [Related]
29. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
Vietzen H; Berger SM; Kühner LM; Furlano PL; Bsteh G; Berger T; Rommer P; Puchhammer-Stöckl E
Cell; 2023 Dec; 186(26):5705-5718.e13. PubMed ID: 38091993
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
31. NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme.
Murad S; Michen S; Becker A; Füssel M; Schackert G; Tonn T; Momburg F; Temme A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628668
[TBL] [Abstract][Full Text] [Related]
32. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
[TBL] [Abstract][Full Text] [Related]
33. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
34. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018.
Mpunga T; Clifford GM; Morgan EA; Milner DA; de Martel C; Munyanshongore C; Muvugabigwi G; Combes JD
Int J Cancer; 2022 Mar; 150(5):753-760. PubMed ID: 34626122
[TBL] [Abstract][Full Text] [Related]
37. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression.
Carbone A; Tirelli U; Gloghini A; Volpe R; Boiocchi M
J Clin Oncol; 1993 Sep; 11(9):1674-81. PubMed ID: 8394878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
